Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · C02 in 2025 · Part C · HD1 Staying Healthy: Screenings, Tests and Vaccines

Colorectal Cancer Screening

Health PlanPreventive CareSource: HEDIS

What it measures
Percent of plan members aged 50-75 who had appropriate screening for colon cancer.
How it's calculated
The percentage of MA enrollees aged 50 to 75 (denominator) as of December 31 of the measurement year who had appropriate screenings for colorectal cancer (numerator).
Data source
HEDIS Patient-level Data
Measurement period
01/01/2023 – 12/31/2023
Better when
Higher
Weight
1 (Process Measure)
Star assignment
Clustering
Case-mix adjusted
No
In improvement measure
Yes
Used in CAI
Yes
HEDIS label
Colorectal Cancer Screening (COL)
Exclusions
Show• Medicare members 66 years of age and older as of December 31 of the measurement year who meet either of the following: – Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. – Living long-term in an institution any time during the measurement year as identified by the LTI flag in the Monthly Membership Detail Data File. • Members 66 years of age and older as of December 31 of the measurement year with frailty and advanced illness during the measurement year. Members must meet both of the frailty and advanced illness criteria to be excluded: 1. – At least two indications of frailty with different dates of service during the measurement year. 2. – Any of the following during the measurement year or the year prior to the measurement year (count services that occur over both years): – At least two outpatient visits, observation visits, ED visits, telephone visits, e- visits or virtual check-ins, nonacute inpatient encounters, or nonacute inpatient discharges. Visit type need not be the same for the two visits. – At least one acute inpatient encounter with an advanced illness diagnosis. – At least one acute inpatient discharge with an advanced illness diagnosis on the discharge claim. – A dispensed dementia medication. • (Required) Exclude members who meet any of the following criteria: – Members who had colorectal cancer or a total colectomy any time during the member’s history through December 31 of the measurement year. – Members receiving palliative care during the measurement year. – Members in hospice or using hospice services during the measurement year. – Members receiving palliative care during the measurement year. – Members who died during the measurement year. Contracts whose enrollment was at least 500 but less than 1,000 as of the enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2023 enrollment report are excluded from this measure.
Disaster policy
Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by 2023 disasters.

From the 2025 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA5960+1
3★MA68680
4★MA75750
5★MA82820

2025 star distribution

Not rated: Plan too small to be measured (80); Plan too new to be measured (60); Plan not required to report measure (52); No data available (31); Not enough data available (24)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA< 59 %>= 59 % to < 68 %>= 68 % to < 75 %>= 75 % to < 82 %>= 82 %
2026MA< 48 %>= 48 % to < 60 %>= 60 % to < 70 %>= 70 % to < 78 %>= 78 %
2025MA< 53 %>= 53 % to < 65 %>= 65 % to < 75 %>= 75 % to < 83 %>= 83 %
2024MA< 48 %>= 48 % to < 60 %>= 60 % to < 71 %>= 71 % to < 80 %>= 80 %
2023MA< 43 %>= 43 % to < 60 %>= 60 % to < 71 %>= 71 % to < 79 %>= 79 %
2022MA< 49 %>= 49 % to < 62 %>= 62 % to < 71 %>= 71 % to < 80 %>= 80 %
2021MA< 43%>= 43% to < 62%>= 62% to < 73%>= 73% to < 80%>= 80%
2020MA< 43%? 43% to < 62%? 62% to < 73%? 73% to < 80%? 80%
2019MA< 55%? 55% to < 63%? 63% to < 72%? 72% to < 79%? 79%
2018MA< 54%? 54% to < 63%? 63% to < 72%? 72% to < 80%? 80%
2017MA< 55%? 55% to < 62%? 62% to < 71%? 71% to < 81%? 81%
2016MA< 51%? 51% to < 63%? 63% to < 71%? 71% to < 78%? 78%
2015MA< 41%? 41% to < 52%? 52% to < 58%? 58% to < 65%? 65%

Lowest-scoring contracts, 2025

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
H9986 Florida Complete CareIndependent Living Systems, LLC1,21861—690%
H6891 American Health Advantage of TexasMitchell Family Office42161—690%
H3727 Communicare AdvantageSNP Holdings, LLC2,314810670%
H2400 Abilis Health (HMO SNP)BrightSpring Health Services, Inc.1,1392010551%
H2392 Kansas Health AdvantageKansas Superior Select8732310521%
H0034 Hamaspik, Inc.Hamaspik of Rockland County, Inc.2,714311—441%
H5969 AlohaCareAlohaCare2,637391−1361%
H5965 WellcareCentene Corporation1,5564210331%
H7512 Ascension CompleteCentene Corporation04610291%
H2128 Wellcare by AllwellCentene Corporation—4610291%
H9900 WellcareCentene Corporation—461—291%
H7518 WellcareCentene Corporation3,2364610291%
R3175 UnitedHealthcareUnitedHealth Group, Inc.0471−1282%
H3015 Shared Health Dual Plus - DE H3015-001 (HMO D-SNP)BlueCross BlueShield of Tennessee—471—282%
H8121 Ascension CompleteCentene Corporation0471—282%
H6399 Aetna MedicareCVS Health Corporation7,2684810273%
H9387 WellcareCentene Corporation8474910263%
H2162 WellcareCentene Corporation04910263%
H7169 Wellcare By AllwellCentene Corporation—501−1253%
H3047 WellcareCentene Corporation—5010253%
H6851 WellSense Health PlanBMC Health System, Inc.4,226511—244%
H6713 WellcareCentene Corporation—5110244%
H7330 Zing HealthZing Health Consolidator, Inc—521−1234%
H0913 WellcareCentene Corporation12,6675320224%
H2853 Ascension CompleteCentene Corporation05420214%

History

Star yearCodeNameMeasuredWeightSource
2027C02Colorectal Cancer Screening01/01/2025 – 12/31/20251HEDIS
2026C02Colorectal Cancer Screening01/01/2024 – 12/31/20241HEDIS
2025C02Colorectal Cancer Screening01/01/2023 – 12/31/20231HEDIS
2024C02Colorectal Cancer Screening01/01/2022 – 12/31/20221HEDIS
2023C02Colorectal Cancer Screening01/01/2021 – 12/31/20211HEDIS
2022C02Colorectal Cancer Screening01/01/2020 – 12/31/20201HEDIS
2021C02Colorectal Cancer Screening01/01/2018 – 12/31/20181HEDIS
2020C02Colorectal Cancer Screening01/01/2018 – 12/31/20181HEDIS
2019C02Colorectal Cancer Screening01/01/2017 – 12/31/20171HEDIS
2018C02Colorectal Cancer Screening01/01/2016 – 12/31/20161HEDIS
2017C02Colorectal Cancer Screening01/01/2015 - 12/31/20151HEDIS
2016C02Colorectal Cancer Screening01/01/2014 - 12/31/20141HEDIS
2015C01Colorectal Cancer Screening01/01/2013 - 12/31/20131HEDIS